Viewing Study NCT00172003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-05-15 @ 10:17 PM
Study NCT ID: NCT00172003
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Cancer View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal Cell Cancer View
None Bone metastasis View
None Skeletal related event View
None Renal Cell Cancer patients with bone metastasis View